Varex Imaging (VREX) Sidoti March Small-Cap Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Sidoti March Small-Cap Virtual Conference summary
18 Mar, 2026Business overview and market position
Operates in X-ray imaging, focusing exclusively on X-ray components for medical (70% of revenue) and industrial (30%) markets.
Maintains long-term relationships with major global OEMs in both medical and industrial sectors.
Tariff mitigation and supply chain strategy
Successfully passed increased tariff costs to customers and shifted to local-for-local manufacturing in China and Europe.
Developed local supply chains and used bonded warehouses to further mitigate tariffs.
Lower tariffs following a Supreme Court decision are expected to benefit P&L in 4–6 months as high-cost inventory is depleted.
Medical market environment and trends
Hospital capital expenditure and discretionary procedure volumes are stable, with imaging remaining a top investment priority.
Channel inventory issues and procurement slowdowns in China have resolved, with stable to improving order intake rates.
New system development with major OEMs has accelerated post-COVID, strengthening engagement and pipeline.
Latest events from Varex Imaging
- Annual guidance, India ramp, photon counting, and AI drive growth and strategic flexibility.VREX
Jefferies Global Healthcare Conference 20263 Jun 2026 - Q2 FY26 revenue rose 1–1.5% to $216M, with non-GAAP EPS at $0.21 and lower leverage from refinancing.VREX
Q2 20268 May 2026 - Stable demand, India ramp-up, and photon counting drive growth and margin outlook.VREX
Oppenheimer 36th Annual Healthcare MedTech & Services Conference17 Mar 2026 - All board nominees, executive pay, and auditor ratification were approved by stockholders.VREX
AGM 202612 Feb 2026 - Revenue up 5% to $210M, 90% EPS growth, strong industrial momentum, and positive Q2 outlook.VREX
Q1 202611 Feb 2026 - Revenue beat guidance, but a $93.9M goodwill impairment led to a GAAP net loss.VREX
Q3 20253 Feb 2026 - Photon counting tech, China recovery, and debt reduction drive 2025 outlook amid trade risks.VREX
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Revenue down 9.9% year-over-year; Medical weak, Industrial up, Q4 outlook cautious.VREX
Q3 20242 Feb 2026 - Photon counting and industrial innovation drive growth amid medical market headwinds and China recovery.VREX
Jefferies 2024 Global Healthcare Conference1 Feb 2026